JPY 720.0
(-0.96%)
Year | Total Liabilities | Total Liabilities Growth |
---|---|---|
2023 | 3.97 Billion JPY | -28.27% |
2022 | 5.54 Billion JPY | -34.47% |
2021 | 8.45 Billion JPY | -5.62% |
2020 | 8.96 Billion JPY | 127.98% |
2019 | 3.93 Billion JPY | -19.57% |
2018 | 4.88 Billion JPY | 5.18% |
2017 | 4.64 Billion JPY | -8.21% |
2016 | 5.06 Billion JPY | 11.1% |
2015 | 4.55 Billion JPY | 28.07% |
2014 | 3.55 Billion JPY | -3.58% |
2013 | 3.68 Billion JPY | -10.35% |
2012 | 4.11 Billion JPY | -4.48% |
2011 | 4.3 Billion JPY | -24.1% |
2010 | 5.67 Billion JPY | -13.89% |
2009 | 6.59 Billion JPY | -5.36% |
2008 | 6.96 Billion JPY | 0.0% |
Year | Total Liabilities | Total Liabilities Growth |
---|---|---|
2024 Q1 | 4.09 Billion JPY | 2.88% |
2023 Q2 | 6.48 Billion JPY | 3.24% |
2023 Q4 | 3.97 Billion JPY | -16.84% |
2023 Q1 | 6.27 Billion JPY | 13.26% |
2023 Q3 | 4.78 Billion JPY | -26.23% |
2023 FY | 3.97 Billion JPY | -28.27% |
2022 Q2 | 9.36 Billion JPY | -9.53% |
2022 Q1 | 10.35 Billion JPY | 22.41% |
2022 FY | 5.54 Billion JPY | -34.47% |
2022 Q4 | 5.54 Billion JPY | 3.0% |
2022 Q3 | 5.38 Billion JPY | -42.55% |
2021 Q2 | 9.35 Billion JPY | 8.99% |
2021 Q1 | 8.58 Billion JPY | -4.24% |
2021 FY | 8.45 Billion JPY | -5.62% |
2021 Q3 | 7.87 Billion JPY | -15.85% |
2021 Q4 | 8.45 Billion JPY | 7.47% |
2020 Q1 | 8.73 Billion JPY | 122.17% |
2020 Q4 | 8.96 Billion JPY | 5.94% |
2020 Q3 | 8.45 Billion JPY | -9.52% |
2020 FY | 8.96 Billion JPY | 127.98% |
2020 Q2 | 9.34 Billion JPY | 7.05% |
2019 Q2 | 4.17 Billion JPY | 13.41% |
2019 FY | 3.93 Billion JPY | -19.57% |
2019 Q4 | 3.93 Billion JPY | 8.25% |
2019 Q3 | 3.63 Billion JPY | -12.99% |
2019 Q1 | 3.68 Billion JPY | -24.71% |
2018 FY | 4.88 Billion JPY | 5.18% |
2018 Q1 | 5.68 Billion JPY | 22.31% |
2018 Q2 | 6.12 Billion JPY | 7.72% |
2018 Q3 | 4.46 Billion JPY | -27.06% |
2018 Q4 | 4.88 Billion JPY | 9.46% |
2017 FY | 4.64 Billion JPY | -8.21% |
2017 Q4 | 4.64 Billion JPY | -1.64% |
2017 Q3 | 4.72 Billion JPY | -0.94% |
2017 Q2 | 4.76 Billion JPY | -3.68% |
2017 Q1 | 4.95 Billion JPY | -2.19% |
2016 FY | 5.06 Billion JPY | 11.1% |
2016 Q4 | 5.06 Billion JPY | 15.03% |
2016 Q3 | 4.4 Billion JPY | -9.68% |
2016 Q2 | 4.87 Billion JPY | 5.23% |
2016 Q1 | 4.62 Billion JPY | 1.61% |
2015 Q3 | 4.11 Billion JPY | -9.55% |
2015 Q4 | 4.55 Billion JPY | 10.63% |
2015 FY | 4.55 Billion JPY | 28.07% |
2015 Q1 | 3.93 Billion JPY | 10.55% |
2015 Q2 | 4.55 Billion JPY | 15.77% |
2014 FY | 3.55 Billion JPY | -3.58% |
2014 Q4 | 3.55 Billion JPY | 5.6% |
2014 Q3 | 3.36 Billion JPY | 0.39% |
2014 Q2 | 3.35 Billion JPY | -0.34% |
2014 Q1 | 3.36 Billion JPY | -8.74% |
2013 Q3 | 3.68 Billion JPY | -2.41% |
2013 Q4 | 3.68 Billion JPY | 0.08% |
2013 FY | 3.68 Billion JPY | -10.35% |
2013 Q1 | 4.33 Billion JPY | 5.26% |
2013 Q2 | 3.77 Billion JPY | -12.8% |
2012 FY | 4.11 Billion JPY | -4.48% |
2012 Q4 | 4.11 Billion JPY | 13.83% |
2012 Q1 | 4.66 Billion JPY | 8.34% |
2012 Q2 | 4.21 Billion JPY | -9.66% |
2012 Q3 | 3.61 Billion JPY | -14.27% |
2011 FY | 4.3 Billion JPY | -24.1% |
2011 Q4 | 4.3 Billion JPY | 13.35% |
2011 Q3 | 3.8 Billion JPY | -33.0% |
2011 Q2 | 5.67 Billion JPY | 0.31% |
2011 Q1 | 5.65 Billion JPY | -0.36% |
2010 Q4 | 5.67 Billion JPY | 13.01% |
2010 FY | 5.67 Billion JPY | -13.89% |
2010 Q3 | 5.02 Billion JPY | -4.42% |
2010 Q2 | 5.25 Billion JPY | -9.46% |
2010 Q1 | 5.8 Billion JPY | -11.95% |
2009 FY | 6.59 Billion JPY | -5.36% |
2009 Q4 | 6.59 Billion JPY | -7.63% |
2009 Q3 | 7.13 Billion JPY | 0.0% |
2008 FY | 6.96 Billion JPY | 0.0% |
Name | Total Liabilities | Total Liabilities Difference |
---|---|---|
Kitanotatsujin Corporation | 1.65 Billion JPY | -140.6% |
Euglena Co., Ltd. | 37.92 Billion JPY | 89.514% |
BEAUTY GARAGE Inc. | 6.49 Billion JPY | 38.754% |
Axas Holdings Co.,Ltd. | 14.58 Billion JPY | 72.728% |
C.I. Medical Co.,Ltd. | 21.36 Billion JPY | 81.39% |
Kao Corporation | 757.7 Billion JPY | 99.475% |
Niitaka Co., Ltd. | 9.35 Billion JPY | 57.501% |
Rohto Pharmaceutical Co.,Ltd. | 99.13 Billion JPY | 95.989% |
Shiseido Company, Limited | 615.1 Billion JPY | 99.354% |
Lion Corporation | 188.22 Billion JPY | 97.887% |
Mandom Corporation | 20.05 Billion JPY | 80.173% |
Ivy Cosmetics Corporation | 1.32 Billion JPY | -199.701% |
Milbon Co., Ltd. | 7.45 Billion JPY | 46.694% |
Nippon Shikizai, Inc. | 13.56 Billion JPY | 70.676% |
Fancl Corporation | 30.56 Billion JPY | 86.992% |
KOSÉ Corporation | 88.61 Billion JPY | 95.513% |
Cota Co., Ltd. | 3.85 Billion JPY | -3.213% |
HABA Laboratories,Inc. | 3.92 Billion JPY | -1.333% |
C'bon Cosmetics Co.,Ltd. | 3.14 Billion JPY | -26.282% |
Pola Orbis Holdings Inc. | 33.26 Billion JPY | 88.045% |
Noevir Holdings Co., Ltd. | 24.04 Billion JPY | 83.46% |
Adjuvant Holdings Co.,Ltd. | 1.06 Billion JPY | -273.692% |
Almado, Inc. | 1.94 Billion JPY | -104.299% |
I-ne CO., LTD. | 8.57 Billion JPY | 53.644% |
Premier Anti-Aging Co., Ltd. | 4.88 Billion JPY | 18.516% |
Liberta Co.,Ltd. | 3.88 Billion JPY | -2.391% |
AXXZIA Inc. | 2 Billion JPY | -98.182% |
S.T. Corporation | 12.01 Billion JPY | 66.894% |
Kobayashi Pharmaceutical Co., Ltd. | 62.65 Billion JPY | 93.653% |
Earth Corporation | 60.4 Billion JPY | 93.417% |
Sagami Rubber Industries Co., Ltd. | 7.79 Billion JPY | 49.009% |
Asahi Eito Holdings Co.,Ltd. | 1.61 Billion JPY | -146.516% |
MTG Co., Ltd. | 11.73 Billion JPY | 66.126% |
TRANSACTION CO.,Ltd. | 4.17 Billion JPY | 4.69% |
SHOBIDO Corporation | 8.89 Billion JPY | 55.307% |
Artnature Inc. | 23.42 Billion JPY | 83.026% |
Pigeon Corporation | 19.34 Billion JPY | 79.449% |
Unicharm Corporation | 345.37 Billion JPY | 98.849% |
Paltac Corporation | 222.34 Billion JPY | 98.212% |
CB GROUP MANAGEMENT Co., Ltd. | 28.51 Billion JPY | 86.054% |